Tel Aviv - Delayed Quote ILA
Lineage Cell Therapeutics, Inc. (LCTX.TA)
169.10
+10.50
+(6.62%)
At close: April 24 at 5:24:34 PM GMT+3
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-23,092
-23,092
-28,566
1,059
-23,561
Investing Cash Flow
-2,308
-2,308
46,449
-46,159
9,745
Financing Cash Flow
35,857
35,857
6,423
1,632
36,930
End Cash Position
46,354
46,354
35,992
11,936
56,277
Interest Paid Supplemental Data
9
9
10
13
13
Capital Expenditure
-565
-565
-674
-413
-340
Issuance of Capital Stock
35,876
35,876
6,426
148
30,865
Repayment of Debt
-54
-54
-54
-32
-20
Repurchase of Capital Stock
-23
-23
-37
-17
-54
Free Cash Flow
-23,657
-23,657
-29,240
646
-23,901
12/31/2021 - 9/8/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CGEN.TA Compugen Ltd.
515.40
-3.95%
ENLV.TA Enlivex Therapeutics Ltd.
337.50
+2.09%
BLRX.TA BioLineRx Ltd.
1.8000
+5.88%
EVGN.TA Evogene Ltd.
389.00
-7.49%
NERV Minerva Neurosciences, Inc.
1.7500
-1.13%
CGEN Compugen Ltd.
1.4800
+2.78%
PPBT Purple Biotech Ltd
2.7300
+1.11%
BLRX BioLineRx Ltd.
3.0021
+0.07%
CLDX Celldex Therapeutics, Inc.
19.58
+0.77%
EVGN Evogene Ltd.
1.1100
+1.83%